Skip to Content

NGL Fine Chem Ltd Unit 1, India, 2025

https://www.myauditor.nl/web/image/product.template/7572/image_1920?unique=14fcff6

GMP Audit Report

Company
NGL Fine Chem Ltd Unit 3

Product(s)
Butaphosphan, Oxfendazole and Triclabendazole

Country
India

Audit Year
2025


0.00 € 0.0 EUR 0.00 €

0.00 €

This combination does not exist.

Butafosfan Oxfendazol Triclabendazole